Table 1.

The IC80 values of the Ph+leukemia cell lines for ST1571 and combined agents*,

DrugKU812K562TCC-STCC-Y
ST1571 (nM) 84 ± 9 247 ± 30 72 ± 6 510 ± 80 
Recombinant IFN-α (IU/mL) 4400 ± 500 > 10 000 1500 ± 300 4500 ± 600 
Natural IFN-α (IU/mL) 2400 ± 400 > 10 000 1100 ± 200 2800 ± 450 
Hydroxyurea (mM) 0.75 ± 0.04 1.1 ± 0.2 0.17 ± 0.02 0.52 ± 0.04 
Cytarabine (nM) 8.9 ± 1.1 92 ± 17 410 ± 56 5.1 ± 0.6 
Homoharringtonine (nM) 56 ± 3 92 ± 11 57 ± 6 80 ± 8 
Doxorubicin (nM) 27 ± 3 70 ± 6 39 ± 6 82 ± 11  
Etoposide (μM) 2.0 ± 0.2 4.2 ± 0.6 2.6 ± 0.4 2.1 ± 0.2 
Hydroperoxy-cyclophosphamide (μM) 4.8 ± 0.6 8.1 ± 0.6 5.3 ± 0.7 3 ± 0.5 
Methotrexate (nM) 14 ± 1 86 ± 7 52 ± 7 64 ± 9 
Vincristine (nM) 0.88 ± 0.03 7.1 ± 0.9 0.75 ± 0.03 0.66 ± 0.02 
DrugKU812K562TCC-STCC-Y
ST1571 (nM) 84 ± 9 247 ± 30 72 ± 6 510 ± 80 
Recombinant IFN-α (IU/mL) 4400 ± 500 > 10 000 1500 ± 300 4500 ± 600 
Natural IFN-α (IU/mL) 2400 ± 400 > 10 000 1100 ± 200 2800 ± 450 
Hydroxyurea (mM) 0.75 ± 0.04 1.1 ± 0.2 0.17 ± 0.02 0.52 ± 0.04 
Cytarabine (nM) 8.9 ± 1.1 92 ± 17 410 ± 56 5.1 ± 0.6 
Homoharringtonine (nM) 56 ± 3 92 ± 11 57 ± 6 80 ± 8 
Doxorubicin (nM) 27 ± 3 70 ± 6 39 ± 6 82 ± 11  
Etoposide (μM) 2.0 ± 0.2 4.2 ± 0.6 2.6 ± 0.4 2.1 ± 0.2 
Hydroperoxy-cyclophosphamide (μM) 4.8 ± 0.6 8.1 ± 0.6 5.3 ± 0.7 3 ± 0.5 
Methotrexate (nM) 14 ± 1 86 ± 7 52 ± 7 64 ± 9 
Vincristine (nM) 0.88 ± 0.03 7.1 ± 0.9 0.75 ± 0.03 0.66 ± 0.02 
*

KU812, K562, and TCC-S were exposed to the drugs for 5 days and TCC-Y for 7 days.

Values represent the mean ± SEM of at least 3 independent experiments.

IC40.

or Create an Account

Close Modal
Close Modal